1. mTORC1 is required for malignant transformation in the Eμ-Myc model.
mTORC1 is required for malignant transformation in the Eμ-Myc model. A, lymphoma-free survival curves for Eμ-Myc mice treated with placebo (n = 34) and everolimus (n = 33). Median survival was 73 days in the placebo arm and was not reached in the everolimus treatment arm (P = ). B, wild-type littermate control mice (WT; n = 8), Eμ-Myc mice treated with placebo (P; n = 34) and with everolimus (E; n = 33) were bled at 4 to 5 weeks of age (t = 0) and after 2, 4, and 8 weeks. Leukocyte counts of individual mice from each group are shown. Horizontal bars represent mean values.
Meaghan Wall et al. Cancer Discovery 2013;3:82-95
©2013 by American Association for Cancer Research